YD Bio Limited Ordinary Shares (YDES) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear

YD Bio Limited Ordinary S...

NASDAQ: YDES · Real-Time Price · USD
18.87
0.37 (1.97%)
At close: Oct 15, 2025, 3:59 PM
18.87
0.00%
After-hours: Oct 15, 2025, 04:10 PM EDT

YD Bio Ordinary Shares Income Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
510.36K 350.13K n/a n/a
Cost of Revenue
355K 196.69K n/a n/a
Gross Profit
155.36K 153.44K n/a n/a
Operating Income
-1.46M -9.85K -2.32M -1.72M
Interest Income
11.81K 290.00 813.00 764.00
Pretax Income
-1.39M 17.65K 3.79M 8.7M
Net Income
-1.41M 13.56K 3.79M 8.7M
Selling & General & Admin
1.13M 160.56K 2.32M 1.72M
Research & Development
491.35K n/a n/a n/a
Other Expenses
-493 2.73K n/a n/a
Operating Expenses
1.62M 163.29K 2.32M 1.72M
Interest Expense
772.00 2.14K n/a n/a
Selling & Marketing Expenses
1.96K 7.49K n/a n/a
Cost & Expenses
1.97M 359.98K 2.32M 1.72M
Income Tax Expense
25.08K 4.09K 2.09K n/a
Shares Outstanding (Basic)
4.15M 70.1M 9.29M 14.63M
Shares Outstanding (Diluted)
4.15M 70.1M 9.29M 14.63M
EPS (Basic)
-0.56 0.00 0.41 0.59
EPS (Diluted)
-0.56 0.00 0.41 0.59
EBITDA
-1.28M 22.25K 3.79M 8.7M
EBIT
-1.39M 19.79K 3.79M 8.7M
Depreciation & Amortization
104.73K 2.45K n/a n/a
Source: Financial Modeling Prep. Financial Sources.
SEC Filings: 10-K · 10-Q